Nirogy Therapeutics is a biotechnology company developing novel small molecules to target cellular transporters. The company is currently advancing a class of small molecules intended to disrupt metabolic and immune mechanisms operative in the tumor microenvironment. Follow-on platform programs are targeting additional disease pathways in oncologyas well as autoimmune diseases.

Biotechnology

Pharmaceutical

Nirogy Therapeutics

Nirogy Therapeutics' headquarters in Natick, MA, United States

Description

People (2)

Nelly Kuklin

Vincent Sandanayaka

Jobs